Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancer

被引:0
|
作者
Burris, HA
Hainsworth, JD
Erland, JB
Morrissey, LH
Kalman, LA
Hon, JK
Scullin, DC
Smith, SW
Greco, FA
机构
[1] Sarah Cannon Canc Ctr, Nashville, TN 37203 USA
[2] Tennessee Oncol, Nashville, TN USA
[3] Oncol Hematol Grp S Florida, Miami, FL USA
[4] Ctr Comprehens Canc, Huntsville, AL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:9 / 13
页数:5
相关论文
共 50 条
  • [1] Triplet chemotherapy with paclitaxel, gemcitabine and carboplatin in advanced non-small cell lung cancer
    Bunn, PA
    Kelly, K
    Mikhaeel, N
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 21 - 21
  • [2] A phase I/II trial of paclitaxel, carboplatin, and gemcitabine in untreated patients with advanced non-small cell lung cancer
    Kelly, K
    Mikhaeel-Kamel, N
    Pan, ZX
    Murphy, J
    Prindiville, S
    Bunn, PA
    CLINICAL CANCER RESEARCH, 2000, 6 (09) : 3474 - 3479
  • [3] A phase I trial of paclitaxel, carboplatin, and gemcitabine in advanced non-small cell lung cancer
    Kelly, K
    Prindiville, S
    Bunn, PA
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 74 - 74
  • [4] Phase II trial of gemcitabine-carboplatin-paclitaxel as neoadjuvant chemotherapy for operable non-small cell lung cancer
    Abratt, Raymond P.
    Lee, Jung Sin
    Han, Ji Youn
    Tsai, Chun-Ming
    Boyer, Michael
    Mok, Ton
    Kim, Sang-We
    Lee, Jin Soo
    Brnabic, Alan J. M.
    Reece, William H. H.
    Lehnert, Manfred
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (02) : 135 - 140
  • [5] Activity of gemcitabine and carboplatin in advanced non-small cell lung cancer: a phase II trial
    Masotti, A
    Zannini, G
    Gentile, A
    Morandini, G
    LUNG CANCER, 2002, 36 (01) : 99 - 103
  • [6] Phase II trial of carboplatin and paclitaxel in non-small cell lung cancer patients previously treated with chemotherapy
    Yoh, Kiyotaka
    Kubota, Kaoru
    Kakinuma, Ryutaro
    Ohmatsu, Hironobu
    Goto, Koichi
    Niho, Seiji
    Saijo, Nagahiro
    Nishiwaki, Yutaka
    LUNG CANCER, 2007, 58 (01) : 73 - 79
  • [7] Phase II Clinical Trial of Genexol® (Paclitaxel) and Carboplatin for Patients with Advanced Non-small Cell Lung Cancer
    Kim, Han Jo
    Kim, Kyoung Ha
    Yun, Jina
    Kim, Se Hyung
    Kim, Hyun Jung
    Lee, Sang-Cheol
    Bae, Sang Byung
    Kim, Chan Kyu
    Lee, Nam Su
    Lee, Kyu Taek
    Kim, Do-Jin
    Park, Seong-Kyu
    Won, Jong-Ho
    Hong, Dae Sik
    Park, Hee Sook
    CANCER RESEARCH AND TREATMENT, 2011, 43 (01): : 19 - 23
  • [8] Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: A phase II trial
    Gatzemeier, U
    Heckmayer, M
    Neuhauss, R
    Schluter, I
    vonPawel, J
    Wagner, H
    Dreps, A
    SEMINARS IN ONCOLOGY, 1995, 22 (06) : 24 - 28
  • [9] A phase II trial of weekly paclitaxel and carboplatin for elderly patients with advanced non-small cell lung cancer (NSCLC).
    Usui, K
    Inoue, A
    Ishimoto, O
    Tanaka, M
    Koinumaru, S
    Matsubara, N
    Kanbe, M
    Gomi, K
    Saijo, Y
    Nukiwa, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 682S - 682S
  • [10] Phase II study of the combination chemotherapy with weekly carboplatin and gemcitabine in advanced non-small cell lung cancer
    Mori, K.
    Kamiyama, Y.
    Kasai, H.
    Kodama, T.
    EJC SUPPLEMENTS, 2009, 7 (02): : 524 - 524